The Pharma Legal Handbook Baltics >> https://bit.ly/324EJz2 >> a comprehensive guide to the legal framework regulating the pharmaceutical sector and related industries! The Handbook is a valuable tool for pharma companies and practitioners operating in the pharmaceutical business to stay in compliance with the various regulations applicable to the industry:
- Answers to the most critical questions about this environment for pharmaceuticals in Estonia, Latvia and Lithuania;
- It is a must-have for any company operating in the country or seeking to enter the market.
The TGS Baltic team Dalia Tamašauskaitė-Žiliene, Sander Kärson, Ingeri Luik-Tamme, Andra Rubene, Audronė Ežerskė, Rokas Kazakevičius and Zane Skļamina have prepared a detailed article presenting: regulation, pricing, clinical and preclinical trials, marketing, manufacturing, trademarks, patents, and more!The Pharma Legal Handbook is an essential guide to the legal and regulatory environment for pharmaceutical companies worldwide.
Although it is not clear when the fundamental EU digital market legislation—Digital Services Act and Digital Markets Act (DMA)—will enter into force (it is unlikely that this will happen before 2023), the mere publication of the drafts and the official European discourse are putting an increasing strain on the big players in digital services. The DMA establishes a long list of specific ex ante obligations for the so-called gatekeepers, i.e. providers of core platforms. These ex ante obligations are mainly aimed at protecting the business models of gatekeepers’ competitors (e.g. requiring business users to use any other core platform service to access core platform services is prohibited, etc.).
Connect with ILN
Firm of the Month
ILN Members Twitter Feed